EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Monitoring Influenza C and D Viruses in Patients With Respiratory Diseases in Japan, January 2018 to March 2023

Kohei Shimizu, Chiharu Kawakami, Yoko Matsuzaki, Seiichiro Fujisaki, Shiho Nagata, Hiroko Morita, Kayo Watanabe, Hideka Miura, Tomoko Momoki, Miwako Saikusa, Hiroki Ozawa, Makoto Kumazaki und 8 weitere

Influenza and Other Respiratory Viruses · 2024

DOI: 10.1111/irv.13345 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Influenza and Other Respiratory Viruses, 2024. Verfasst von Kohei Shimizu und 19 weiteren Autor:innen. Beteiligte Einrichtung: Yokohama City Institute of Public Health, Yokohama, Kanagawa, Japan. Hauptthemen laut MEDLINE: Influenza, Human, Triazines, Gammainfluenzavirus, Pyridones. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health, Labour and Welfare, Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Influenza viruses can cause zoonotic infections that pose public health risks. Surveillance of influenza A and B viruses is conducted globally; however, information on influenza C and D viruses is limited. Longitudinal monitoring of influenza C virus in humans has been conducted in several countries, but there has been no long‐term monitoring of influenza D virus in humans. The public health risks associated with the influenza D virus therefore remain unknown.

Methods

We established a duplex real‐time RT‐PCR to detect influenza C and D viruses and analyzed respiratory specimens collected from 2144 patients in Japan with respiratory diseases between January 2018 and March 2023. We isolated viruses and conducted hemagglutination inhibition tests to examine antigenicity and focus reduction assays to determine susceptibility to the cap‐dependent endonuclease inhibitor baloxavir marboxil.

Results

We detected three influenza C viruses belonging to the C/Kanagawa‐ or C/Sao Paulo‐lineages, which recently circulated globally. None of the specimens was positive for the influenza D virus. The C/Yokohama/1/2022 strain, isolated from the specimen with the highest viral RNA load and belonging to the C/Kanagawa‐lineage, showed similar antigenicity to the reference C/Kanagawa‐lineage strain and was susceptible to baloxavir.

Conclusions

Our duplex real‐time RT‐PCR is useful for the simultaneous detection of influenza C and D viruses from the same specimen. Adding the influenza D virus to the monitoring of the influenza C virus would help in assessing the public health risks posed by this virus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza, HumanTriazinesGammainfluenzavirusPyridonesDibenzothiepinsHumansJapanMaleFemaleMiddle AgedAdultAgedAntiviral AgentsMorpholinesHemagglutination Inhibition TestsChild, PreschoolChildAdolescentYoung AdultThogotovirusReal-Time Polymerase Chain ReactionInfantAged, 80 and over

Stichwörter der Autor:innen

influenza Cinfluenza Dsurveillancezoonotic infection

Substanzen

baloxavirTriazinesPyridonesDibenzothiepinsAntiviral AgentsMorpholines

Autor:innen und Institutionen

  • Yokohama City Institute of Public Health, Yokohama, Kanagawa, Japan.
  • Pandemic Preparedness, Infection, and Advanced Research Center, The University of Tokyo, Tokyo, Japan.
  • Research Center for Global Viral Diseases, National Center for Global Health and Medicine Research Institute, Tokyo, Japan.
  • Department of Infectious Diseases, Yamagata University Faculty of Medicine, Yamagata, Japan.
  • Research Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, Tokyo, Japan.
  • Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.

ORCID-Profile: Emi Takashita

Förderung

  • Ministry of Health, Labour and Welfare
  • Japan Society for the Promotion of Science
  • Japan Agency for Medical Research and Development

Zitieren

APA

Shimizu, K., Kawakami, C., Matsuzaki, Y., Fujisaki, S., Nagata, S., Morita, H., Watanabe, K., Miura, H., Momoki, T., Saikusa, M., Ozawa, H., Kumazaki, M., Usuku, S., Tanaka, N., Senda, R., Okubo, I., Watanabe, S., Hasegawa, H., Kawaoka, Y., & Takashita, E. (2024). Monitoring Influenza C and D Viruses in Patients With Respiratory Diseases in Japan, January 2018 to March 2023. Influenza and Other Respiratory Viruses. https://doi.org/10.1111/irv.13345

Vancouver

Shimizu K, Kawakami C, Matsuzaki Y, Fujisaki S, Nagata S, Morita H, et al. Monitoring Influenza C and D Viruses in Patients With Respiratory Diseases in Japan, January 2018 to March 2023. Influenza and Other Respiratory Viruses. 2024. doi:10.1111/irv.13345

BibTeX
@article{Shimizu2024,
  author = {Shimizu, Kohei and Kawakami, Chiharu and Matsuzaki, Yoko and Fujisaki, Seiichiro and Nagata, Shiho and Morita, Hiroko and Watanabe, Kayo and Miura, Hideka and Momoki, Tomoko and Saikusa, Miwako and Ozawa, Hiroki and Kumazaki, Makoto and Usuku, Shuzo and Tanaka, Nobuko and Senda, Ryuichi and Okubo, Ichiro and Watanabe, Shinji and Hasegawa, Hideki and Kawaoka, Yoshihiro and Takashita, Emi},
  title = {Monitoring Influenza C and D Viruses in Patients With Respiratory Diseases in Japan, January 2018 to March 2023},
  journal = {Influenza and Other Respiratory Viruses},
  year = {2024},
  doi = {10.1111/irv.13345}
}
Kostenlos starten →